DE102015117945A1 - Blutgefäßersatz, vor allem Kleindurchmesserblutgefäßersatz - Google Patents
Blutgefäßersatz, vor allem Kleindurchmesserblutgefäßersatz Download PDFInfo
- Publication number
- DE102015117945A1 DE102015117945A1 DE102015117945.8A DE102015117945A DE102015117945A1 DE 102015117945 A1 DE102015117945 A1 DE 102015117945A1 DE 102015117945 A DE102015117945 A DE 102015117945A DE 102015117945 A1 DE102015117945 A1 DE 102015117945A1
- Authority
- DE
- Germany
- Prior art keywords
- blood vessel
- vessel replacement
- nanofibers
- microfibers
- pcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 76
- 239000002121 nanofiber Substances 0.000 claims abstract description 36
- 229920001610 polycaprolactone Polymers 0.000 claims abstract description 35
- 239000004632 polycaprolactone Substances 0.000 claims abstract description 34
- 229920001410 Microfiber Polymers 0.000 claims abstract description 21
- 229920001577 copolymer Polymers 0.000 claims abstract description 21
- 239000003658 microfiber Substances 0.000 claims abstract description 21
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 claims abstract description 14
- 239000004626 polylactic acid Substances 0.000 claims abstract description 8
- 210000002889 endothelial cell Anatomy 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 15
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 14
- 239000013543 active substance Substances 0.000 claims description 14
- 230000012010 growth Effects 0.000 claims description 10
- 210000000329 smooth muscle myocyte Anatomy 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 8
- 229920002988 biodegradable polymer Polymers 0.000 claims description 6
- 239000004621 biodegradable polymer Substances 0.000 claims description 6
- 206010061218 Inflammation Diseases 0.000 claims description 5
- 230000004054 inflammatory process Effects 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 230000023555 blood coagulation Effects 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 57
- 238000009987 spinning Methods 0.000 description 36
- 239000000835 fiber Substances 0.000 description 22
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000001878 scanning electron micrograph Methods 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920001432 poly(L-lactide) Polymers 0.000 description 5
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 206010020718 hyperplasia Diseases 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 102100037362 Fibronectin Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000005686 electrostatic field Effects 0.000 description 2
- 238000010041 electrostatic spinning Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- QJSFZHSTNBFQKU-UHFFFAOYSA-N imino(dioxido)azanium Chemical class [O-][N+]([O-])=N QJSFZHSTNBFQKU-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- ICRHORQIUXBEPA-UHFFFAOYSA-N thionitrous acid Chemical compound SN=O ICRHORQIUXBEPA-UHFFFAOYSA-N 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZPV2015-159 | 2015-03-06 | ||
| CZ2015-159A CZ306213B6 (cs) | 2015-03-06 | 2015-03-06 | Cévní náhrada, zejména maloprůměrová cévní náhrada |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102015117945A1 true DE102015117945A1 (de) | 2016-09-08 |
Family
ID=56738393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE102015117945.8A Ceased DE102015117945A1 (de) | 2015-03-06 | 2015-10-21 | Blutgefäßersatz, vor allem Kleindurchmesserblutgefäßersatz |
Country Status (2)
| Country | Link |
|---|---|
| CZ (1) | CZ306213B6 (cs) |
| DE (1) | DE102015117945A1 (cs) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3517141A1 (en) * | 2018-01-26 | 2019-07-31 | Technicka univerzita v Liberci | Dressing for acute or chronic wound |
| CN114569790A (zh) * | 2022-03-14 | 2022-06-03 | 新乡医学院 | 具有促内皮化及抗凝双功能的人工血管及制备方法、用途 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4629932A1 (en) * | 2022-12-06 | 2025-10-15 | Medical 21, Inc. | Composite implant |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ294274B6 (cs) | 2003-09-08 | 2004-11-10 | Technická univerzita v Liberci | Způsob výroby nanovláken z polymerního roztoku elektrostatickým zvlákňováním a zařízení k provádění způsobu |
| DE102005048939A1 (de) | 2005-07-01 | 2007-01-11 | Carl Freudenberg Kg | Vorrichtung, Anordnung und Verfahren zur Herstellung von Fasern und eine solche Fasern umfassende Anordnung |
| JP2008127726A (ja) | 2006-11-24 | 2008-06-05 | Matsushita Electric Ind Co Ltd | ナノファイバーの製造装置 |
| CZ299549B6 (cs) | 2006-09-04 | 2008-08-27 | Elmarco, S. R. O. | Rotacní zvláknovací elektroda |
| CZ300345B6 (cs) | 2007-07-17 | 2009-04-22 | Elmarco, S. R. O. | Zpusob zvláknování kapalné matrice, zarízení pro výrobu nanovláken elektrostatickým zvláknováním kapalné matrice a zvláknovací elektroda pro takové zarízení |
| CZ2008529A3 (cs) | 2008-09-01 | 2010-03-10 | Elmarco S.R.O. | Zarízení pro výrobu vrstvy nanovláken elektrostatickým zvláknováním polymerní matrice |
| CZ304137B6 (cs) | 2012-12-17 | 2013-11-13 | Technická univerzita v Liberci | Zpusob výroby polymerních nanovláken zvláknováním roztoku nebo taveniny polymeru v elektrickém poli a lineární útvar z polymerních nanovláken vytvorený tímto zpusobem |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003072748A2 (en) * | 2002-02-22 | 2003-09-04 | University Of Washington | Bioengineered tissue substitutes |
| US20070298072A1 (en) * | 2004-11-19 | 2007-12-27 | Teijin Limited | Cylindrical Body and Manufacturing Method Thereof |
| US7637941B1 (en) * | 2005-05-11 | 2009-12-29 | Advanced Cardiovascular Systems, Inc. | Endothelial cell binding coatings for rapid encapsulation of bioerodable stents |
| EP2111185B1 (en) * | 2007-01-30 | 2017-12-20 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Bioerodible wraps and uses therefor |
-
2015
- 2015-03-06 CZ CZ2015-159A patent/CZ306213B6/cs not_active IP Right Cessation
- 2015-10-21 DE DE102015117945.8A patent/DE102015117945A1/de not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ294274B6 (cs) | 2003-09-08 | 2004-11-10 | Technická univerzita v Liberci | Způsob výroby nanovláken z polymerního roztoku elektrostatickým zvlákňováním a zařízení k provádění způsobu |
| DE102005048939A1 (de) | 2005-07-01 | 2007-01-11 | Carl Freudenberg Kg | Vorrichtung, Anordnung und Verfahren zur Herstellung von Fasern und eine solche Fasern umfassende Anordnung |
| CZ299549B6 (cs) | 2006-09-04 | 2008-08-27 | Elmarco, S. R. O. | Rotacní zvláknovací elektroda |
| JP2008127726A (ja) | 2006-11-24 | 2008-06-05 | Matsushita Electric Ind Co Ltd | ナノファイバーの製造装置 |
| CZ300345B6 (cs) | 2007-07-17 | 2009-04-22 | Elmarco, S. R. O. | Zpusob zvláknování kapalné matrice, zarízení pro výrobu nanovláken elektrostatickým zvláknováním kapalné matrice a zvláknovací elektroda pro takové zarízení |
| CZ2008529A3 (cs) | 2008-09-01 | 2010-03-10 | Elmarco S.R.O. | Zarízení pro výrobu vrstvy nanovláken elektrostatickým zvláknováním polymerní matrice |
| CZ304137B6 (cs) | 2012-12-17 | 2013-11-13 | Technická univerzita v Liberci | Zpusob výroby polymerních nanovláken zvláknováním roztoku nebo taveniny polymeru v elektrickém poli a lineární útvar z polymerních nanovláken vytvorený tímto zpusobem |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3517141A1 (en) * | 2018-01-26 | 2019-07-31 | Technicka univerzita v Liberci | Dressing for acute or chronic wound |
| CN114569790A (zh) * | 2022-03-14 | 2022-06-03 | 新乡医学院 | 具有促内皮化及抗凝双功能的人工血管及制备方法、用途 |
| CN114569790B (zh) * | 2022-03-14 | 2022-09-02 | 新乡医学院 | 具有促内皮化及抗凝双功能的人工血管及制备方法、用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2015159A3 (cs) | 2016-10-05 |
| CZ306213B6 (cs) | 2016-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11071617B2 (en) | Biomedical patches with aligned fibers | |
| Biazar et al. | Types of neural guides and using nanotechnology for peripheral nerve reconstruction | |
| Daristotle et al. | A review of the fundamental principles and applications of solution blow spinning | |
| Neves et al. | Patterning of polymer nanofiber meshes by electrospinning for biomedical applications | |
| Pillay et al. | A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications | |
| JP6048878B2 (ja) | ろ過手段として使用するための布地材料複合構造 | |
| Ebersole et al. | Development of novel electrospun absorbable polycaprolactone (PCL) scaffolds for hernia repair applications | |
| EP1457552B1 (de) | Trägermaterial für die Gewebe- und Zellkultur, zur Herstellung von Implantaten oder Implantatmaterialien, und ein mit dem Trägermaterial hergestelltes Implantat | |
| WO2018144858A1 (en) | Methods of improving bone-soft tissue healing using electrospun fibers | |
| WO2016192733A1 (en) | Conduit for regeneration of biological material | |
| Panahi-Joo et al. | Design and fabrication of a nanofibrous polycaprolactone tubular nerve guide for peripheral nerve tissue engineering using a two-pole electrospinning system | |
| Jose et al. | Seamless, axially aligned, fiber tubes, meshes, microbundles and gradient biomaterial constructs | |
| CN110869063A (zh) | 用于肌腱/韧带组织的再生和/或置换的分层多尺度电纺支架及其生产方法 | |
| Zhang et al. | Aligned soy protein isolate-modified poly (L-lactic acid) nanofibrous conduits enhanced peripheral nerve regeneration | |
| DE102015117945A1 (de) | Blutgefäßersatz, vor allem Kleindurchmesserblutgefäßersatz | |
| Polk et al. | Pneumatospinning of collagen microfibers from benign solvents | |
| Bader et al. | Recent advances in the applications of continuous and non-continuous nanofibrous yarns in biomedicine | |
| DE102015117941A1 (de) | Verfahren und Einrichtung zur Erzeugung eines die polymeren Nanofasern enthaltenden Textilkompositmaterials, Textilkompositmaterial, das die polymeren Nanofasern enthält | |
| Lin et al. | Poly-l-lactide/sodium alginate/chitosan microsphere hybrid scaffolds made with braiding manufacture and adhesion technique: Solution to the incongruence between porosity and compressive strength | |
| Cozzens et al. | Electrospinning of biostable polyisobutylene‐based thermoplastic polyurethanes | |
| DE102010025302A1 (de) | Stent mit elektrogesponnener Faserbeschichtung, hülsenförmiger Vlieskörper sowie Verfahren zu deren Herstellung | |
| Biazar et al. | Nanotechnology for peripheral nerve regeneration | |
| Tong et al. | Electrospinning of Fibrous PHBV Tissue Engineering Scaffolds: Fiber diameter control, fiber alignment and mechanical properties | |
| KR102738710B1 (ko) | 나노 트랩 및 그 제조방법 | |
| DE102024106304A1 (de) | Gefäßprothese; Verfahren zur Herstellung einer Gefäßprothese |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R012 | Request for examination validly filed | ||
| R082 | Change of representative |
Representative=s name: CANZLER & BERGMEIER PATENTANWAELTE, DE Representative=s name: PATENTANWAELTE CANZLER & BERGMEIER PARTNERSCHA, DE |
|
| R016 | Response to examination communication | ||
| R002 | Refusal decision in examination/registration proceedings | ||
| R003 | Refusal decision now final |